EDIXOMED LIMITED

🌳Matureactive
SC363191 · ltd · incorporated 2009-07-28
Investment thesis
Well-run mature business — low negotiation leverage; premium likely.
Why interesting: Textbook target; clean filings, stable trading.
Why risky: No pressure on seller; any deal likely at full price.
Opportunity decay
hardening · 12-months
Already tight — no obvious softening catalysts on the horizon.
  • · Thesis: well-run, low negotiation leverage
🔒Estimated value
Upgrade to see
Turnover
not disclosed
Net worth
book net assets
Opportunity
73/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
Pass (distressed without resilience)
Distressed active trading company — structural issues outweigh the discount.

Opportunity 73/100 (strong), bankability 75/100. Strong seller-intent signal (63/100, director aged 81). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: 1 insolvency-related filing on record. Filings relating to insolvency, liquidation, or administration exist in the company's history. Review before proceeding. Most likely exit: share sale to pe / searcher (65/100).

Data confidence

Overall: medium (60/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
No iXBRL financials extracted
0
Lenders & charges
Confirmed no charges registered
85
Directors & officers
8 officers (3 active, 8 linked, 6 with DOB)
85
Ownership & PSC
1 active PSC(s) of 2 total, 2 with control declared
90
Director network
18 connected companies via shared directors
90
Filing history
86 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
73/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
75
Strong succession / seller-readiness signals.
Risk profile
67
Some moderate concerns — review flags.
Signal strength
90
Good data coverage for analysis.

Recent activity

Last 30 days
4
filings
  • 2 accounts
  • 2 other
Last 90 days
4
filings
  • 2 accounts
  • 2 other
Last 180 days
4
filings
  • 2 accounts
  • 2 other
Counts from Companies House filing history.
Corporate timeline (35 events)Click to expand
  1. 2026-04-21
    📄
    accounts-with-accounts-type-audit-exemption-subsiduary
    accounts · AA
  2. 2026-04-21
    📄
    legacy
    accounts · PARENT_ACC
  3. 2026-04-21
    📄
    legacy
    other · GUARANTEE2
  4. 2026-04-21
    📄
    legacy
    other · AGREEMENT2
  5. 2025-04-02
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  6. 2025-04-02
    📄
    legacy
    accounts · PARENT_ACC
  7. 2025-04-02
    📄
    legacy
    other · AGREEMENT2
  8. 2025-04-02
    📄
    legacy
    other · GUARANTEE2
  9. 2024-03-09
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  10. 2024-03-09
    📄
    legacy
    accounts · PARENT_ACC
  11. 2024-03-09
    📄
    legacy
    other · AGREEMENT2
  12. 2024-03-09
    📄
    legacy
    other · GUARANTEE2
  13. 2023-09-28
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  14. 2023-09-25
    GRIFFITH, Hugh Stephen resigned
    director
  15. 2023-07-18
    BARNES, Justin David Christian resigned
    director
  16. 2023-07-18
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  17. 2023-03-27
    📄
    accounts-with-accounts-type-small
    accounts · AA
  18. 2023-03-21
    📄
    capital-statement-capital-company-with-date-currency-figure
    capital · SH19
  19. 2023-03-21
    ⚠️
    legacy
    insolvency · CAP-SS
  20. 2023-03-21
    📄
    legacy
    capital · SH20
  21. 2023-03-21
    📄
    resolution
    resolution · RESOLUTIONS
  22. 2023-02-02
    📄
    second-filing-of-confirmation-statement-with-made-up-date
    confirmation-statement · RP04CS01
  23. 2022-03-04
    📄
    accounts-with-accounts-type-small
    accounts · AA
  24. 2019-03-01
    QUINN, Martin Alexander resigned
    secretary
  25. 2016-02-01
    ADAMSON, Moira resigned
    secretary
  26. 2016-02-01
    QUINN, Martin Alexander appointed
    secretary
  27. 2014-09-29
    LIPMAN, Keith appointed
    director
  28. 2012-10-01
    ADAMSON, Moira appointed
    secretary
  29. 2012-05-24
    HANNA, Wilfred Sydney appointed
    director
  30. 2012-04-18
    BARNES, Justin David Christian appointed
    director
  31. 2012-03-01
    QUINN, Martin Alexander resigned
    director
  32. 2011-05-01
    WOOD, Christopher Barry, Prof appointed
    director
  33. 2011-05-01
    GRIFFITH, Hugh Stephen appointed
    director
  34. 2009-07-28
    🏢
    Company incorporated
    As EDIXOMED LIMITED
  35. 2009-07-28
    QUINN, Martin Alexander appointed
    director

Owner dependency

65/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Founder age: Director aged approximately 81 — succession pressure is live.

Succession & seller-readiness

83/100
Likely off-market candidate

Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.

SIGNALS
  • primaryFounder aged 70+: Senior director is approximately 81 years old. Natural succession window is now.
  • secondary12+ year tenure: Director in role 15 years.
  • secondaryStable-but-static management: Company is 17 years old and no new directors in the last 3 years — succession not yet being planned internally.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

1 high ·
1 insolvency-related filing on record
high

Filings relating to insolvency, liquidation, or administration exist in the company's history. Review before proceeding.

Evidence: 2023-03-21: legacy

Group structure

Thirty Holdings Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.

🏛️
Thirty Holdings Limited
Corporate parent · holds 75-100% shares · board control
ultimate parent
EDIXOMED LIMITED
This company · SC363191

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Thirty Holdings Limited
Corporate entity
75100%
75–100%board control75-100% shares · 75-100% voting · board control16/11/2018
1 historic (ceased) PSC
  • Mr Christopher Barry Woodceased 16/11/2018· 25-50% shares · 25-50% voting

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · EH postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
EDEN SCOTT LTD
SC243605 · est 2003 · no financials extracted
23y
EDINBURGH PROVISIONS IP LTD
SC608480 · est 2018 · no financials extracted
7y
EDINBURGH SUPERCAR HIRE LIMITED
SC672787 · est 2020 · no financials extracted
5y
EDMOND FINANCIAL SERVICES LIMITED
SC449778 · est 2013 · no financials extracted
12y
EDYN CREATIVE LTD
SC549493 · est 2016 · no financials extracted
9y
EILDON MANAGEMENT LIMITED
SC374222 · est 2010 · no financials extracted
16y
ELECTRIFY MARKETING & COMMUNICATIONS LIMITED
SC522448 · est 2015 · no financials extracted
10y
ELECTRINET LTD
SC881075 · est 2026 · no financials extracted
ELEMENT AERO LTD
SC650842 · est 2020 · no financials extracted
6y
ELEPHANT STONE LIMITED
SC333079 · est 2007 · no financials extracted
18y
ELEUSIS LTD
SC836388 · est 2025 · no financials extracted
1y
ELISTERE ACCOUNTING SERVICES LTD
SC627390 · est 2019 · no financials extracted
7y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2009-07-28
Jurisdictionscotland
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

1 Lochrin Square
92-98 Fountainbridge
Edinburgh
EH3 9QA
United Kingdom

Filing status

Accounts
Next due: 2027-04-30
Last made up to: 2025-07-31
Confirmation statement
Next due: 2026-08-11
Last: 2025-07-28

Officers (3 active · 5 resigned)

HANNA, Wilfred Sydney
director · ~59y · appointed 2012-05-24
View their other companies + combined net worth →
Active
LIPMAN, Keith
director · ~55y · appointed 2014-09-29
View their other companies + combined net worth →
Active
WOOD, Christopher Barry, Prof
director · ~81y · appointed 2011-05-01
View their other companies + combined net worth →
Active
ADAMSON, Moira
secretary · appointed 2012-10-01 · resigned 2016-02-01
Resigned
QUINN, Martin Alexander
secretary · appointed 2016-02-01 · resigned 2019-03-01
Resigned
BARNES, Justin David Christian
director · ~60y · appointed 2012-04-18 · resigned 2023-07-18
Resigned
GRIFFITH, Hugh Stephen
director · ~58y · appointed 2011-05-01 · resigned 2023-09-25
Resigned
QUINN, Martin Alexander
director · ~56y · appointed 2009-07-28 · resigned 2012-03-01
Resigned

Click a director name to see their full track record across all companies.

Recent filings (86 total)

accounts-with-accounts-type-audit-exemption-subsiduary
accounts · AA
2026-04-21
legacy
accounts · PARENT_ACC
2026-04-21
legacy
other · GUARANTEE2
2026-04-21
legacy
other · AGREEMENT2
2026-04-21
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-07-29
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-04-02
legacy
accounts · PARENT_ACC
2025-04-02
legacy
other · AGREEMENT2
2025-04-02
legacy
other · GUARANTEE2
2025-04-02
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-08-05
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-03-09
legacy
accounts · PARENT_ACC
2024-03-09
legacy
other · AGREEMENT2
2024-03-09
legacy
other · GUARANTEE2
2024-03-09
termination-director-company-with-name-termination-date
officers · TM01
2023-09-28